Gene Page: CCNT1
Summary ?
GeneID | 904 |
Symbol | CCNT1 |
Synonyms | CCNT|CYCT1|HIVE1 |
Description | cyclin T1 |
Reference | MIM:143055|HGNC:HGNC:1599|Ensembl:ENSG00000129315|HPRD:03938|Vega:OTTHUMG00000170393 |
Gene type | protein-coding |
Map location | 12q13.11 |
Pascal p-value | 0.386 |
Sherlock p-value | 0.562 |
Fetal beta | 0.954 |
DMG | 1 (# studies) |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
DMG:Nishioka_2013 | Genome-wide DNA methylation analysis | The authors investigated the methylation profiles of DNA in peripheral blood cells from 18 patients with first-episode schizophrenia (FESZ) and from 15 normal controls. | 1 |
Expression | Meta-analysis of gene expression | P value: 1.606 |
Section I. Genetics and epigenetics annotation
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg22103585 | 12 | 49110427 | CCNT1 | -0.032 | 0.46 | DMG:Nishioka_2013 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs9637082 | chr21 | 21213235 | CCNT1 | 904 | 0.14 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0003677 | DNA binding | IDA | 16109376 | |
GO:0005515 | protein binding | IPI | 12944466 | |
GO:0017069 | snRNA binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | TAS | 9499409 | |
GO:0006355 | regulation of transcription, DNA-dependent | IEA | - | |
GO:0006350 | transcription | IEA | - | |
GO:0006468 | protein amino acid phosphorylation | IPI | 16109376 | |
GO:0006366 | transcription from RNA polymerase II promoter | TAS | 9499409 | |
GO:0007049 | cell cycle | IEA | - | |
GO:0051301 | cell division | IEA | - | |
GO:0044419 | interspecies interaction between organisms | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005634 | nucleus | IDA | 12944466 | |
GO:0005654 | nucleoplasm | EXP | 7853496 |12676794 | |
GO:0005730 | nucleolus | IDA | 16109376 |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
AFF4 | AF5Q31 | MCEF | MGC75036 | AF4/FMR2 family, member 4 | - | HPRD,BioGRID | 12065898 |
AHR | - | aryl hydrocarbon receptor | - | HPRD,BioGRID | 12917420 |
CCNK | CPR4 | MGC9113 | cyclin K | in vitro in vivo | BioGRID | 10574912 |
CDK9 | C-2k | CDC2L4 | CTK1 | PITALRE | TAK | cyclin-dependent kinase 9 | - | HPRD | 9872325 |10465067 |10617616 |11145967 |11689688 |11713532 |11713533 |12115727 |12894230 |14627702 |15528190 |
CDK9 | C-2k | CDC2L4 | CTK1 | PITALRE | TAK | cyclin-dependent kinase 9 | CyclinT1 interacts with Cdk9. | BIND | 9499409 |
CDK9 | C-2k | CDC2L4 | CTK1 | PITALRE | TAK | cyclin-dependent kinase 9 | CycT1 interacts with CDK9. This interaction was modeled on a demonstrated interaction between CycT1 from an unspecified species and human CDK9. | BIND | 15546612 |
CDK9 | C-2k | CDC2L4 | CTK1 | PITALRE | TAK | cyclin-dependent kinase 9 | Affinity Capture-Western in vitro in vivo Phenotypic Suppression Reconstituted Complex Two-hybrid | BioGRID | 9499409 |10656684 |10958691 |11689688 |12588988 |12832472 |12944466 |15107825 |
CDK9 | C-2k | CDC2L4 | CTK1 | PITALRE | TAK | cyclin-dependent kinase 9 | Cyclin T1 interacts with CDK9. | BIND | 12588988 |
CDK9 | C-2k | CDC2L4 | CTK1 | PITALRE | TAK | cyclin-dependent kinase 9 | - | HPRD | 9499409 |10958691 |
GRIPAP1 | DKFZp434P0630 | GRASP-1 | KIAA1167 | MGC126593 | MGC126595 | GRIP1 associated protein 1 | in vitro in vivo | BioGRID | 11704662 |
GRN | GEP | GP88 | PCDGF | PEPI | PGRN | granulin | - | HPRD,BioGRID | 12588988 |
GRN | GEP | GP88 | PCDGF | PEPI | PGRN | granulin | Cyclin T1 interacts with granulin. | BIND | 12588988 |
HEXIM1 | CLP1 | EDG1 | FLJ13562 | HIS1 | MAQ1 | hexamethylene bis-acetamide inducible 1 | - | HPRD,BioGRID | 12832472 |
HTATSF1 | TAT-SF1 | dJ196E23.2 | HIV-1 Tat specific factor 1 | - | HPRD,BioGRID | 10913173 |11780068 |
MDFIC | HIC | MyoD family inhibitor domain containing | Affinity Capture-Western Reconstituted Complex Two-hybrid | BioGRID | 12944466 |
MYBL2 | B-MYB | BMYB | MGC15600 | v-myb myeloblastosis viral oncogene homolog (avian)-like 2 | Phenotypic Suppression | BioGRID | 10656684 |
MYC | bHLHe39 | c-Myc | v-myc myelocytomatosis viral oncogene homolog (avian) | - | HPRD,BioGRID | 12944920 |
NCOA2 | GRIP1 | KAT13C | MGC138808 | NCoA-2 | TIF2 | nuclear receptor coactivator 2 | Cyclin T1 interacts with GRIP1. | BIND | 11704662 |
NUFIP1 | NUFIP | bA540M5.1 | nuclear fragile X mental retardation protein interacting protein 1 | Affinity Capture-Western Reconstituted Complex | BioGRID | 15107825 |
NUFIP1 | NUFIP | bA540M5.1 | nuclear fragile X mental retardation protein interacting protein 1 | CyclinT1 interacts with NUFIP. | BIND | 15107825 |
PML | MYL | PP8675 | RNF71 | TRIM19 | promyelocytic leukemia | - | HPRD,BioGRID | 12727882 |
PURA | PUR-ALPHA | PUR1 | PURALPHA | purine-rich element binding protein A | - | HPRD,BioGRID | 11730934 |
SKP2 | FBL1 | FBXL1 | FLB1 | MGC1366 | S-phase kinase-associated protein 2 (p45) | - | HPRD | 11689688 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 27 | 17 | All SZGR 2.0 genes in this pathway |
REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 38 | 26 | All SZGR 2.0 genes in this pathway |
REACTOME GENERIC TRANSCRIPTION PATHWAY | 352 | 181 | All SZGR 2.0 genes in this pathway |
REACTOME RNA POL II TRANSCRIPTION | 105 | 54 | All SZGR 2.0 genes in this pathway |
REACTOME TRANSCRIPTION | 210 | 127 | All SZGR 2.0 genes in this pathway |
REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | 45 | 19 | All SZGR 2.0 genes in this pathway |
REACTOME ELONGATION ARREST AND RECOVERY | 32 | 14 | All SZGR 2.0 genes in this pathway |
REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | 61 | 32 | All SZGR 2.0 genes in this pathway |
REACTOME HIV INFECTION | 207 | 122 | All SZGR 2.0 genes in this pathway |
REACTOME HIV LIFE CYCLE | 125 | 69 | All SZGR 2.0 genes in this pathway |
REACTOME HOST INTERACTIONS OF HIV FACTORS | 132 | 81 | All SZGR 2.0 genes in this pathway |
REACTOME LATE PHASE OF HIV LIFE CYCLE | 104 | 61 | All SZGR 2.0 genes in this pathway |
REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | 63 | 42 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA DN | 1375 | 806 | All SZGR 2.0 genes in this pathway |
SHEN SMARCA2 TARGETS DN | 357 | 212 | All SZGR 2.0 genes in this pathway |
NOUZOVA TRETINOIN AND H4 ACETYLATION | 143 | 85 | All SZGR 2.0 genes in this pathway |
WEIGEL OXIDATIVE STRESS BY HNE AND H2O2 | 39 | 29 | All SZGR 2.0 genes in this pathway |
MAHAJAN RESPONSE TO IL1A UP | 81 | 52 | All SZGR 2.0 genes in this pathway |
MONNIER POSTRADIATION TUMOR ESCAPE UP | 393 | 244 | All SZGR 2.0 genes in this pathway |
WHITEFORD PEDIATRIC CANCER MARKERS | 116 | 63 | All SZGR 2.0 genes in this pathway |
LABBE TGFB1 TARGETS DN | 108 | 64 | All SZGR 2.0 genes in this pathway |
MILI PSEUDOPODIA HAPTOTAXIS DN | 668 | 419 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS UP | 504 | 321 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE MIDDLE | 98 | 56 | All SZGR 2.0 genes in this pathway |
PURBEY TARGETS OF CTBP1 AND SATB1 DN | 180 | 116 | All SZGR 2.0 genes in this pathway |
KOHOUTEK CCNT1 TARGETS | 50 | 26 | All SZGR 2.0 genes in this pathway |
LE NEURONAL DIFFERENTIATION DN | 19 | 16 | All SZGR 2.0 genes in this pathway |
ZWANG CLASS 1 TRANSIENTLY INDUCED BY EGF | 516 | 308 | All SZGR 2.0 genes in this pathway |